2015
Subgroup Analysis of Topical Tranexamic Acid in Primary Total Hip Arthroplasty
Anazonwu W, Tuttle J, Rubin L. Subgroup Analysis of Topical Tranexamic Acid in Primary Total Hip Arthroplasty. Reconstructive Review 2015, 5 DOI: 10.15438/rr.5.1.80.Peer-Reviewed Original ResearchTotal hip arthroplastyPrimary total hip arthroplastyTopical tranexamic acidTranexamic acidTXA administrationBlood lossHip arthroplastyBlood product transfusionSpecific patient groupsTotal joint arthroplastyPreoperative hemoglobinTransfusion reductionProduct transfusionTHA patientsAntifibrinolytic agentsPatient groupSurgical approachIntraarticular injectionSubgroup analysisJoint arthroplastyArthroplastyPatientsAdministrationSubgroupsStudy model
2014
Cost Benefit Analysis of Topical Tranexamic Acid in Primary Total Hip and Knee Arthroplasty
Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE. Cost Benefit Analysis of Topical Tranexamic Acid in Primary Total Hip and Knee Arthroplasty. The Journal Of Arthroplasty 2014, 29: 1512-1515. PMID: 24630599, DOI: 10.1016/j.arth.2014.01.031.Peer-Reviewed Original ResearchConceptsTopical tranexamic acidPrimary total hipTranexamic acidTotal hipKnee arthroplastyTopical TXAPostoperative hemoglobinTransfusion rateAdverse eventsRetrospective cohortConsecutive patientsHospital dispositionArthroplasty patientsPrimary hipDelta hemoglobinTransfusion costsHome dispositionNursing facilitiesPatientsHipArthroplastyHemoglobinCohort